PRESSURE BIOSCIENCES, INC. Debt Instrument, Convertible, Beneficial Conversion Feature
PRESSURE BIOSCIENCES, INC. reported Debt Instrument, Convertible, Beneficial Conversion Feature of $1.32 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-04-05.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature · last filed 2022-04-05
- PRESSURE BIOSCIENCES, INC. debt instrument, convertible, beneficial conversion feature for the quarter ending 2021-12-31 was $88.80K.
- PRESSURE BIOSCIENCES, INC. debt instrument, convertible, beneficial conversion feature for the quarter ending 2021-09-30 was $664.68K.
- PRESSURE BIOSCIENCES, INC. debt instrument, convertible, beneficial conversion feature for the quarter ending 2021-06-30 was $513.07K.
- PRESSURE BIOSCIENCES, INC. debt instrument, convertible, beneficial conversion feature for the quarter ending 2021-03-31 was $53.78K, a 86.84% decline year-over-year.
- PRESSURE BIOSCIENCES, INC. debt instrument, convertible, beneficial conversion feature for fiscal 2021 was $1.32M.
- PRESSURE BIOSCIENCES, INC. debt instrument, convertible, beneficial conversion feature for fiscal 2018 was $12.88M.
- PRESSURE BIOSCIENCES, INC. debt instrument, convertible, beneficial conversion feature for fiscal 2016 was -$20.72K.
| Period end | Debt Instrument, Convertible, Beneficial Conversion Feature 3 month | Debt Instrument, Convertible, Beneficial Conversion Feature 6 month | Debt Instrument, Convertible, Beneficial Conversion Feature 9 month | Debt Instrument, Convertible, Beneficial Conversion Feature 12 month |
|---|---|---|---|---|
| 2021-12-31 | $88.80K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-05 | $753.48K derived: sum of 2 quarters · filed 2022-04-05 | $1.27M derived: sum of 3 quarters · filed 2022-04-05 | $1.32M 10-K · filed 2022-04-05 |
| 2021-09-30 | $664.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-17 | $1.18M derived: sum of 2 quarters · filed 2021-11-17 | $1.23M 10-Q · filed 2021-11-17 | |
| 2021-06-30 | $513.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-18 | $566.85K 10-Q · filed 2021-08-18 | ||
| 2021-03-31 | $53.78K 10-Q · filed 2021-05-17 | |||
| 2020-09-30 | $1.35M 10-Q · filed 2020-11-16 | |||
| 2020-03-31 | $408.61K 10-Q · filed 2020-06-29 | |||
| 2018-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-16 | $2.35M derived: sum of 2 quarters · filed 2019-04-16 | $12.88M 10-K · filed 2019-04-16 | |
| 2018-09-30 | $1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $11.68M 10-Q · filed 2018-11-14 | ||
| 2018-06-30 | $10.53M 10-Q · filed 2018-08-14 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | -$12.76K derived: sum of 2 quarters · filed 2017-03-22 | -$20.72K 10-K · filed 2017-03-22 | |
| 2016-09-30 | -$12.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$20.72K 10-Q · filed 2016-11-14 | ||
| 2016-06-30 | -$7.96K 10-Q · filed 2016-08-15 |